Your search returned 36 studies. (Get alerts for new studies):
- Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Conditions: Graft vs Host Disease - Hematologic Neoplasm
1 Location available
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Flu
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- A Study to Lower the Occurrences and Severity of Graft-versus-host Disease
Conditions: Graft vs Host Disease
2 Locations available
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
56 Locations available
- Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- High-Dose Cyclophosphamide in Treating Patients With Acute Graft-Versus-Host Disease That Did Not Respond to Steroid Therapy
Conditions: Graft Versus Host Disease
1 Location available
- Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Conditions: Graft-Versus-Host Disease
1 Location available
- Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease
1 Location available
- Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Conditions: Graft Versus Host Disease
1 Location available
- Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
Conditions: Oral Chronic Graft-versus-host Disease
4 Locations available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Conditions: Graft Versus Host Disease - Recurrent Adult Acute Lymphoblastic Leukemia
2 Locations available
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle
Conditions: Peripheral Blood Stem Cell Transplantation - Anemia, Sickle Cell - Graft-Versus-Host Disease - Sirolimus (Rapamune(Registered Trademark)) - Alemtuzumab (Campath(Registered Trademark))
1 Location available
- Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Leukemia, Myeloid, Accelerated Phase - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Blast Phase - Contiguous Stage II Adult Burkitt's Lymphoma - Contiguous S
1 Location available
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Conditions: Chronic GVHD
39 Locations available
- Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease
Conditions: Graft-Versus-Host Disease
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Conditions: Chronic Graft-versus-host Disease
1 Location available
- Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Conditions: Graft vs Host Disease
1 Location available
- Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease - Chronic Graft vs Host Disease - cGVHD
2 Locations available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
1 Location available
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Lymphoblastic Leukemia in Remission - Adult
2 Locations available
- Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Conditions: Sclerodermoid Chronic Graft-versus-host Disease - Graft Versus Host Disease in Skin
5 Locations available
- Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
Conditions: Graft Versus Host Disease (GVHD)
1 Location available
- Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-host Disease
1 Location available
- The Natural History of Graft-Versus-Host Disease in the Eyes
Conditions: Graft-Versus-Host Disease
1 Location available
- Factors Determining Outcomes in Patients With Graft-Versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Conditions: Cutaneous T Cell Lymphoma - Graft Versus Host Disease
1 Location available
- Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Conditions: Acute Graft Versus Host Disease
1 Location available
- Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease
1 Location available
- Clobetasol for Oral Graft-Versus-Host Disease
Conditions: Oral Chronic Graft vs Host Disease
1 Location available
|